Latvia vs Estonia vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 98% | 83% |
| 2023 | 97% | 85% |
| 2022 | 96% | 87% |
| 2021 | 97% | 89% |
| 2020 | 99% | 91% |
| 2019 | 99% | 88% |
| 2018 | 98% | 87% |
| 2017 | 96% | 93% |
| 2016 | 93% | 93% |
| 2015 | 96% | 93% |
| 2014 | 95% | 93% |
| 2013 | 96% | 94% |
| 2012 | 90% | 94% |
| 2011 | 92% | 94% |
| 2010 | 95% | 95% |
| 2009 | 92% | 95% |
| 2008 | 96% | 95% |
| 2007 | 95% | 96% |
| 2006 | 98% | 96% |
| 2005 | 98% | 96% |
| 2004 | 98% | 96% |
| 2003 | 98% | 95% |
| 2002 | 98% | 95% |
| 2001 | 98% | 95% |
| 2000 | 97% | 93% |
| 1999 | 97% | 92% |
| 1998 | 97% | 89% |
| 1997 | 97% | 88% |
| 1996 | 96% | 86% |
| 1995 | 81% | 81% |
| 1994 | 81% | 76% |
| 1993 | 80% | 74% |
| 1992 | 95% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 97% | 81% |
| 2023 | 98% | 84% |
| 2022 | 95% | 87% |
| 2021 | 94% | 90% |
| 2020 | 99% | 91% |
| 2019 | 99% | 91% |
| 2018 | 96% | 92% |
| 2017 | 98% | 93% |
| 2016 | 98% | 93% |
| 2015 | 94% | 93% |
| 2014 | 92% | 93% |
| 2013 | 94% | 94% |
| 2012 | 91% | 94% |
| 2011 | 92% | 93% |
| 2010 | 92% | 94% |
| 2009 | 94% | 95% |
| 2008 | 94% | 95% |
| 2007 | 94% | 95% |
| 2006 | 96% | 95% |
| 2005 | 99% | 96% |
| 2004 | 99% | 94% |
| 2003 | 98% | 94% |
| 2002 | 97% | 94% |
| 2001 | 97% | 94% |
| 2000 | 96% | 93% |
| 1999 | 95% | 91% |
| 1998 | 94% | 88% |
| 1997 | 92% | 87% |
| 1996 | 93% | 87% |
| 1995 | 98% | 82% |
| 1994 | 97% | 77% |
| 1993 | 80% | 71% |
| 1992 | 87% | - |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 99% | 81% |
| 2023 | 97% | 82% |
| 2022 | 95% | 83% |
| 2021 | 94% | 84% |
| 2020 | 99% | 90% |
| 2019 | 99% | 91% |
| 2018 | 96% | 93% |
| 2017 | 98% | 92% |
| 2016 | 98% | 93% |
| 2015 | 94% | 91% |
| 2014 | 92% | 93% |
| 2013 | 94% | 93% |
| 2012 | 90% | 94% |
| 2011 | 89% | 94% |
| 2010 | 91% | 94% |
| 2009 | 92% | 95% |
| 2008 | 93% | 94% |
| 2007 | 91% | 95% |
| 2006 | 94% | 95% |
| 2005 | 99% | 95% |
| 2004 | 98% | 90% |
| 2003 | 98% | - |
| 2002 | 98% | - |
| 2001 | 96% | - |
| 2000 | 95% | - |
| 1999 | 94% | - |
| 1998 | 9% | - |
| 1997 | 6% | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 98% of children aged 12–23 months in Latvia and 83% in Estonia: 15 percentage points more in Latvia. The third DTP dose reaches 97% in Latvia and 81% in Estonia, 16 points more in Latvia. The third hepatitis B dose reaches 99% in Latvia and 81% in Estonia, 18 points more in Latvia. In 1993, the first measles dose reached 80% in Latvia and 74% in Estonia, 6 percentage points more in Latvia.
Latvia vs Estonia: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 98% (2024) | 83% (2024) |
| DTP3 | 97% (2024) | 81% (2024) |
| HepB3 | 99% (2024) | 81% (2024) |
Latvia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Estonia and nearby countries: measles vaccination (MCV1), % of children aged 12–23 months
Of Latvia and its four neighbors, the latest coverage of the first measles dose is highest in Latvia, at 98%, and lowest in Estonia, at 83%; of Estonia and the five nearby countries, the latest coverage of the first measles dose is highest in Latvia, at 98%, and lowest in Estonia, at 83%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.